Shandong Simcere

Simcere Pharmaceutical Group is a leading innovation-driven pharmaceutical company in China, focusing on oncology, central nervous system diseases, and autoimmune disorders. The company maintains a robust integrated platform for R&D, manufacturing, and commercialization, with a growing portfolio of innovative drugs and first-to-market generics. Simcere is notably recognized for its rapid response to public health needs, such as the development of anti-SARS-CoV-2 treatments, and its strategic collaborations with international biotech firms. With multiple state-of-the-art manufacturing facilities, including significant operations in Shandong, the company is transitioning from a traditional pharma model to a global innovation leader.